Treatment for HIV typically begins immediately, often the same day as diagnosis. Current U.S. guidelines recommend starting antiretroviral therapy (ART) as soon as possible after an HIV diagnosis, regardless of how healthy you feel or how high your immune cell counts are. This is a significant shift from earlier decades, when doctors waited until the immune system showed signs of weakening before prescribing medication.
Why Treatment Starts Right Away
The recommendation for immediate treatment is backed by strong evidence. The landmark START trial, one of the largest HIV treatment studies ever conducted, found that people who began ART immediately had a 57% lower risk of serious illness or death compared to those who delayed treatment until their immune system declined. Even after the delayed group eventually started medication, the early-treatment group maintained a measurable health advantage for years.
Starting treatment quickly also benefits public health. Once ART brings the virus to undetectable levels in the blood, a person with HIV effectively cannot transmit the virus sexually. The faster treatment begins, the shorter the window during which transmission is possible.
Same-Day Start Programs
Many clinics now offer what’s called “rapid start” or same-day ART, where you receive your first dose of medication during the same visit you’re diagnosed or referred to care. In one U.S. public health program studying this approach, 95% of patients offered same-day treatment started medication within 24 hours. Those patients reached viral suppression (meaning the virus was driven to very low levels in the blood) in a median of about 56 days from their clinic referral, compared to 170 days for patients treated under the older, slower approach.
That speed matters. The sooner the virus is suppressed, the less damage it does to the immune system and the sooner the risk of passing HIV to others drops to effectively zero.
Lab Tests and Starting Treatment
You might wonder whether doctors need to run a battery of tests before prescribing anything. In practice, clinics draw blood for baseline labs like viral load measurement and drug resistance testing, but these results don’t need to come back before you take your first dose. Guidelines explicitly note that when ART is started soon after diagnosis, repeating baseline labs is unnecessary. The initial prescription is chosen to work against the vast majority of HIV strains, and your doctor can adjust the regimen later if resistance testing reveals anything unusual.
In same-day start programs, regimen changes after initial lab results come back are fairly common and expected. In the rapid-start study mentioned above, several patients had their medication simplified to a single daily pill once genetic test results confirmed which drugs would work best. These adjustments are routine, not a sign that something went wrong.
When Treatment May Be Briefly Delayed
There are a few rare situations where starting ART on the same day isn’t recommended. The main exceptions involve certain serious infections of the brain and central nervous system, particularly cryptococcal meningitis and tuberculosis that has spread to the brain. In these cases, doctors treat the infection first for a short period before adding HIV medication. The reason is a phenomenon called immune reconstitution inflammatory syndrome (IRIS), where the rapidly recovering immune system can trigger a dangerous inflammatory reaction against an existing infection in the brain. This scenario is rare in outpatient settings and mostly arises in people who are already seriously ill at diagnosis.
Outside of these specific central nervous system infections, the standard guidance is to start ART without delay.
Treatment During Pregnancy
For pregnant individuals newly diagnosed with HIV, treatment also begins as soon as possible. The urgency is even greater because ART reduces the risk of passing the virus to the baby during pregnancy and delivery. Certain medications are preferred during pregnancy because they lower viral load rapidly, which is especially important when someone is diagnosed late in pregnancy and there’s limited time before delivery.
What Happens After You Start
Most people who take ART consistently reach an undetectable viral load within one to six months. “Undetectable” means the amount of virus in your blood is so low that standard tests can’t measure it. At that point, the virus is no longer damaging your immune system, and you cannot transmit HIV sexually.
Modern ART regimens are typically one to two pills taken once daily. Side effects are generally mild compared to older HIV medications. In the rapid-start study, only about 5% of patients experienced even minor side effects from their initial regimen. Your doctor will monitor your viral load and immune cell counts periodically to confirm the medication is working and make adjustments if needed.
What Counts as Late Treatment
The World Health Organization defines advanced HIV disease as having a CD4 cell count below 200 cells per cubic millimeter of blood, or presenting with a serious AIDS-defining illness. A healthy immune system typically has CD4 counts between 500 and 1,500. Falling below 200 means the immune system is severely compromised, leaving you vulnerable to infections that a healthy body would easily fight off.
People who are diagnosed late or who delay starting treatment are more likely to reach this threshold. The START trial illustrated this clearly: the group that deferred treatment had more than twice the risk of serious health events compared to the immediate-treatment group during the study period. Even after the deferred group started ART and their immune counts recovered, the gap in health outcomes took years to narrow. Starting treatment early avoids this entirely, which is why the current consensus is so firmly in favor of beginning medication right away.